{"cik":1671502,"taxonomy":"us-gaap","tag":"InterestExpense","label":"Interest Expense","description":"Amount of the cost of borrowed funds accounted for as interest expense.","entityName":"Quoin Pharmaceuticals, Ltd.","units":{"USD":[{"start":"2020-01-01","end":"2020-12-31","val":47021,"accn":"0001104659-22-045620","fy":2021,"fp":"FY","form":"20-F","filed":"2022-04-14","frame":"CY2020"},{"start":"2021-01-01","end":"2021-06-30","val":268111,"accn":"0001410578-22-002665","fy":2022,"fp":"Q2","form":"6-K","filed":"2022-08-18"},{"start":"2021-04-01","end":"2021-06-30","val":202514,"accn":"0001410578-22-002665","fy":2022,"fp":"Q2","form":"6-K","filed":"2022-08-18","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-12-31","val":1090409,"accn":"0001104659-22-045620","fy":2021,"fp":"FY","form":"20-F","filed":"2022-04-14","frame":"CY2021"}]}}